Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 11

Results For "IDA"

1727 News Found

EMA validates MAAs for AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan in two types of cancer
Drug Approval | March 07, 2024

EMA validates MAAs for AstraZeneca and Daiichi Sankyo’s datopotamab deruxtecan in two types of cancer

The validations confirm the completion of the applications and commence the scientific review process


Unichem Laboratories posts Q3 FY24 consolidated PAT at Rs. 83.99 Cr
News | February 06, 2024

Unichem Laboratories posts Q3 FY24 consolidated PAT at Rs. 83.99 Cr

Unichem Laboratories has reported total income of Rs. 445.65 crores during the period ended December 31, 2023


KIMS posts Q3 FY24 consolidated PAT at Rs. 71.84 Cr
News | February 05, 2024

KIMS posts Q3 FY24 consolidated PAT at Rs. 71.84 Cr

KIMS has reported total income of Rs. 609.091 crores during the period ended December 31, 2023


Thyrocare Technologies posts Q3 FY24 consolidated PAT at Rs. 15.35 Cr
News | February 03, 2024

Thyrocare Technologies posts Q3 FY24 consolidated PAT at Rs. 15.35 Cr

Thyrocare Technologies has reported total income of Rs. 137.47 crores during the period ended December 31, 2023


Dr Lal Path Labs posts Q3 FY24 consolidated PAT at Rs. 81.3 Cr
News | February 03, 2024

Dr Lal Path Labs posts Q3 FY24 consolidated PAT at Rs. 81.3 Cr

Dr. Lal Path Labs has reported total income of Rs. 557.2 crores during the period ended December 31, 2023


GMM Pfaudler posts Q3 FY24 consolidated PAT at Rs. 31.72 Cr
News | February 03, 2024

GMM Pfaudler posts Q3 FY24 consolidated PAT at Rs. 31.72 Cr

GMM Pfaudler has reported total income of Rs. 848.28 crores during the period ended December 31, 2023


Max Healthcare Institute Ltd Q3 FY24 consolidated profit up at Rs. 289.34 Cr
News | February 02, 2024

Max Healthcare Institute Ltd Q3 FY24 consolidated profit up at Rs. 289.34 Cr

Max Healthcare Institute has reported total income of Rs. 1380.99 crores during the period ended December 31, 2023


Dabur India posts Q3 FY24 consolidated PAT at Rs. 514.22 Cr
News | February 02, 2024

Dabur India posts Q3 FY24 consolidated PAT at Rs. 514.22 Cr

Dabur India has reported total income of Rs. 3382.43 crores during the period ended December 31, 2023


Vimta Labs posts Q3 FY24 consolidated PAT at Rs. 10.13 Cr
News | February 02, 2024

Vimta Labs posts Q3 FY24 consolidated PAT at Rs. 10.13 Cr

Vimta Labs has reported total income of Rs. 82.57 crores during the period ended December 31, 2023


Morepen Laboratories reports Q3 FY24 consolidated PAT at Rs. 31.99 Cr
News | February 02, 2024

Morepen Laboratories reports Q3 FY24 consolidated PAT at Rs. 31.99 Cr

Morepen Laboratories has reported total income of Rs. 448.62 crores during the period ended December 31, 2023